Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

Movement Disorders

Volumn 16, Issue 2, 2001, Pages 185-189

  Turmel, Hélène ^a   Hartmann, Andreas ^a   Parain, Karine ^a   Douhou, Aicha ^a   Srinivasan, Anu ^b   Agid, Yves ^a   Hirsch, Etienne C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b PFIZER INC   (United States)

Author keywords

Apoptosis; Caspase 3; MPP+; MPTP; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CASPASE 3; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL LOSS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; IMMUNOREACTIVITY; IN VIVO STUDY; INTOXICATION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NEURONS; PARKINSON DISEASE, SECONDARY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0035297146     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.1037     Document Type: Article

References (17)

1. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 1999;57:86-94.
2. Cutillas B, Espejo M, Gil J, Ferrer I, Ambrosio S. Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration. NeuroReport 1999;10:2605-2608.
3. Dodel RC, Du Y, Bales KR., Ling ZD, Carvey PM, Paul SM. Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridium-induced toxicity of cultured fetal rat mesencephalic dopamine neurons. Neuroscience 1998;86:701-707.
4. Du Y, Dodel RC, Bales KR, Jemmerson R, Hamilton-Byrd E, Paul SM. Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J Neurochem 1997;69:1382-1388.
5. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.
6. Franklin BJ, Paxinos G. The mouse brain in stereotaxic coordinates. San Diego: Academic Press; 1997.
7. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI., Agid Y, Hirsch EC. Caspase-3: a vulnerability factor and a final effector in the apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000;97:2875-2880.
8. Hirsch EC, Graybiel AM, Agid Y. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988;334:345-348.
9. Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H, Tatton WG, Tatton N, Olanow WC. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord 1999; 14:383-385.
10. Jeon BS, Kholodilov NG, Oo TF, Kim SY, Tomaselli KJ, Srinivasan A, Stefanis L, Burke RE. Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 1999;73:322-333.
11. Lotharius J, Dugan LL, O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 1999;19:1284-1293.
12. Mochizuki H, Nakamura N, Nishi K, Mizuno Y. Apoptosis induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic striatal co-culture in rat. Neurosci Lett 1994;170:191-194.
13. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB. Neuroprotection by the inhibition of apoptosis. Brain Pathol 2000;10:283-292.
14. Schulz JB, Weller M, Moskowitz MA. Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol 1999; 45:421-429.
15. Spooren WPJM, Gentsch C, Wiessner C. TUNEL-positive cells in the substantia nigra of C57BL/6 mice after a single bolus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 1998;85:649-651.
16. Srinivasan A, Roth KA, Sayers RO, Shindler KS, Wong AM, Fritz LC, Tomaselli KJ. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ 1998;12:1004-1016.
17. Tatton NA, Kish S. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 1997;77:1037-1048.